DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Horizon Pharma, Inc.

NASDAQ: HZNP

2.37 0.05 (2.16%)

REAL-TIME: Last trade at

Extended Hours: $2.37 $0.00 (0.00%)
Quote as of (NASDAQ)


company name or ticker

Recent Quotes

HZNP $2.37 2.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.30
Previous Close $2.32
Daily Range $2.29 - $2.38
52-Week Range $1.97 - $8.72
Market Cap $148.8M
P/E Ratio -1.41
Dividend (Yield) $0.00 (0.0%)
Volume 299,145
Average Daily Volume 253,656
Current FY EPS -$1.29

Sector

Healthcare

Industry

Drugs

Horizon Pharma, Inc. (HZNP) Description

Horizon Pharma Inc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis pain and inflammatory diseases. Website: http://www.horizonpharma.com/

News & Commentary Rss Feed

Commit To Buy Horizon Pharma At $1, Earn 15%

Horizon Pharma CEO Discuses Q1 2013 Results - Earnings Call Transcript

Ask a Fool: Buffett's Biggest Misconception

What do people get wrong the most when they think of Warren Buffett?

Whoa! These 3 Stocks Just Beat the Dow

These stocks bounced higher yesterday, but are they about to make a return trip to Earth?

Market Close: Big Winners & Losers for March 25, 2013 (STXS, NVGN, LEDS, HZNP, BVX, IDIX, TOPS, SINO

Market Close: Big Winners & Losers for March 25, 2013 (STXS, NVGN, LEDS, HZNP, BVX, IDIX, TOPS, SINO, PGTI, HALO)

3 Stocks That Blew the Market Away

These three companies posted better-than-expected earnings last week.

Has Horizon Pharma's Share Price Bottomed Out?

UPDATE: Piper Jaffray Reiterates Horizon Pharma at Neutral Following Q4 Earnings

Horizon Pharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript

Horizon Pharma Tops EPS Estimates, Falls Short on Revenue

See More HZNP News...